Abstract
Progesterone (P4) and estradiol (E2) regulate many cell functions through their interaction with specific intracellular receptors, which require the participation of coactivators such as SRC-1 and SRC-3 for enhancing their transcriptional activity. Coactivator expression is altered in many cancers and in some of them their expression is regulated by P4 and E2. In this study, we determined progesterone and estrogen receptor isoform expression in two human astrocytoma cell lines with different evolution grade (U373, grade III; and D54, grade IV) by Western Blot. We studied the role of P4 and E2 on SRC-1 and SRC-3 expression in U373 and D54 cell lines by RT–PCR and Western blot. In U373 cells, P4 did not modify SRC-1 expression, but in D54 cells it increased SRC-1 mRNA expression after 12 h of treatment without significant changes after 24 h. P4 also increased SRC-1 protein content after 24 h, but reduced it after 48 h. E2 did not change SRC-1 expression in any cell line. SRC-3 expression was not regulated by either E2 or P4. Our data suggest that SRC-1 and SRC-3 expression is differentially regulated by sex steroid hormones in astrocytomas and that P4 regulates SRC-1 expression depending on the evolution grade of human astrocytoma cells.
Similar content being viewed by others
References
C. Daumas-Duport, B. Scheithauer, J. O’Fallon, P. Kelly, Cancer 62(10), 2152–2165 (1988)
B.A. Barres, Neuron 60(3), 430–440 (2008)
U.M. Schrell, E.F. Adams, R. Fahlbusch, R. Greb, G. Jirikowski, R. Prior, F.J. Ramalho-Ortigao, J. Neurosurg. 73(5), 743–749 (1990)
S.M. Grunberg, M.H. Weiss, I.M. Spitz, J. Ahmadi, A. Sadun, C.A. Russell, L. Lucci, L.L. Stevenson, J. Neurosurg. 74(6), 861–866 (1991)
J.E. Levine, P.E. Chappell, J.S. Schneider, N.C. Sleiter, M. Szabo, Front. Neuroendocrinol. 22(2), 69–106 (2001)
M. Schumacher, H. Coirini, F. Robert, R. Guennoun, M. El-Etr, Behav. Brain Res. 105(1), 37–52 (1999)
O. Villamar-Cruz, J. Manjarrez-Marmolejo, R. Alvarado, I. Camacho-Arroyo, Brain Res. Bull. 69(3), 276–281 (2006)
R.S. Carroll, J. Zhang, K. Dashner, M. Sar, P.M. Black, Neurosurgery 37(3), 496–503 (1995). discussion 503–494
H. Khalid, S. Shibata, M. Kishikawa, A. Yasunaga, M. Iseki, T. Hiura, Cancer 80(11), 2133–2140 (1997)
C. Bozzetti, R. Camisa, R. Nizzoli, L. Manotti, A. Guazzi, N. Naldi, S. Mazza, V. Nizzoli, G. Cocconi, Surg. Neurol. 43(3), 230–233 (1995). discussion 234
A. Omulecka, W. Papierz, A. Nawrocka-Kunecka, I. Lewy-Trenda, Folia Neuropathol. 44(2), 111–115 (2006)
I. Camacho-Arroyo, G. Gonzalez-Aguero, A. Gamboa-Dominguez, M.A. Cerbon, R. Ondarza, J. Neurooncol. 49(1), 1–7 (2000)
J. Honegger, C. Renner, R. Fahlbusch, E.F. Adams, Neurosurgery 41(6), 1359–1363 (1997). discussion 1363–1354
G. Gonzalez-Aguero, R. Ondarza, A. Gamboa-Dominguez, M.A. Cerbon, I. Camacho-Arroyo, Brain Res. Bull. 56(1), 43–48 (2001)
M. Assimakopoulou, G. Sotiropoulou-Bonikou, T. Maraziotis, J. Varakis, Clin. Neuropathol. 17(1), 27–34 (1998)
A. Batistatou, D. Stefanou, A. Goussia, E. Arkoumani, A.G. Papavassiliou, N.J. Agnantis, J. Cancer Res. Clin. Oncol. 130(7), 405–410 (2004)
G. Gonzalez-Aguero, A.A. Gutierrez, D. Gonzalez-Espinosa, J.D. Solano, R. Morales, A. Gonzalez-Arenas, E. Cabrera-Munoz, I. Camacho-Arroyo, Endocrine 32(2), 129–135 (2007)
A. Gonzalez-Arenas, B. Aguilar-Maldonado, S.E. Avendano-Vazquez, J.A. Garcia-Sainz, Mol. Pharmacol. 70(1), 154–162 (2006)
E. Cabrera-Munoz, A. Gonzalez-Arenas, M. Saqui-Salces, J. Camacho, F. Larrea, R. Garcia-Becerra, I. Camacho-Arroyo, J. Steroid Biochem. Mol. Biol. 113(1–2), 80–84 (2009)
S.A. Onate, S.Y. Tsai, M.J. Tsai, B.W. O’Malley, Science 270(5240), 1354–1357 (1995)
C.K. Glass, M.G. Rosenfeld, Genes Dev. 14(2), 121–141 (2000)
N.J. McKenna, R.B. Lanz, B.W. O’Malley, Endocr. Rev. 20(3), 321–344 (1999)
S.L. Anzick, J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, X.Y. Guan, G. Sauter, O.P. Kallioniemi, J.M. Trent, P.S. Meltzer, Science 277(5328), 965–968 (1997)
Y. Hayashi, S. Ohmori, T. Ito, H. Seo, Biochem. Biophys. Res. Commun. 236(1), 83–87 (1997)
J. Grenier, A. Trousson, A. Chauchereau, J. Cartaud, M. Schumacher, C. Massaad, Mol. Endocrinol. 20(2), 254–267 (2006)
E. Kalkhoven, J.E. Valentine, D.M. Heery, M.G. Parker, EMBO J. 17(1), 232–243 (1998)
C. Leo, J.D. Chen, Gene 245(1), 1–11 (2000)
J. Xu, Q. Li, Mol. Endocrinol. 17(9), 1681–1692 (2003)
X. Li, J. Wong, S.Y. Tsai, M.J. Tsai, B.W. O’Malley, Mol. Cell Biol. 23(11), 3763–3773 (2003)
S.J. Han, J. Jeong, F.J. Demayo, J. Xu, S.Y. Tsai, M.J. Tsai, B.W. O’Malley, Mol. Cell Biol. 25(18), 8150–8165 (2005)
H. Ogawa, M. Nishi, M. Kawata, Brain Res. 890(2), 197–202 (2001)
E. Nishihara, B.W. O’Malley, J. Xu, Mol. Neurobiol. 30(3), 307–325 (2004)
H.A. Molenda, A.L. Griffin, A.P. Auger, M.M. McCarthy, M.J. Tetel, Endocrinology 143(2), 436–444 (2002)
A. Vienonen, S. Miettinen, T. Manninen, L. Altucci, E. Wilhelm, T. Ylikomi, Eur. J. Endocrinol. 148(4), 469–479 (2003)
C.B. Weldon, S. Elliott, Y. Zhu, J.L. Clayton, T.J. Curiel, B.M. Jaffe, M.E. Burow, Surgery 136(2), 346–354 (2004)
H. Kishimoto, Z. Wang, P. Bhat-Nakshatri, D. Chang, R. Clarke, H. Nakshatri, Carcinogenesis 26(10), 1706–1715 (2005)
S. Wang, Y. Yuan, L. Liao, S.Q. Kuang, J.C. Tien, B.W. O’Malley, J. Xu, Proc. Natl. Acad. Sci. USA 106(1), 151–156 (2009)
H. Sakaguchi, J. Fujimoto, W.S. Sun, T. Tamaya, J. Steroid Biochem. Mol. Biol. 104(3–5), 237–240 (2007)
C. Sakakura, A. Hagiwara, R. Yasuoka, Y. Fujita, M. Nakanishi, K. Masuda, A. Kimura, Y. Nakamura, J. Inazawa, T. Abe, H. Yamagishi, Int. J. Cancer 89(3), 217–223 (2000)
H.J. Zhou, J. Yan, W. Luo, G. Ayala, S.H. Lin, H. Erdem, M. Ittmann, S.Y. Tsai, M.J. Tsai, Cancer Res. 65(17), 7976–7983 (2005)
S. Bautista, H. Valles, R.L. Walker, S. Anzick, R. Zeillinger, P. Meltzer, C. Theillet, Clin. Cancer Res. 4(12), 2925–2929 (1998)
J. Kurebayashi, T. Otsuki, H. Kunisue, K. Tanaka, S. Yamamoto, H. Sonoo, Clin. Cancer Res. 6(2), 512–518 (2000)
S. Misiti, L. Schomburg, P.M. Yen, W.W. Chin, Endocrinology 139(5), 2493–2500 (1998)
Y.A. Mitev, S.S. Wolf, O.F. Almeida, V.K. Patchev, Faseb. J. 17(3), 518–519 (2003)
F.J. Fleming, A.D. Hill, E.W. McDermott, N.J. O’Higgins, L.S. Young, J. Clin. Endocrinol. Metab. 89(1), 375–383 (2004)
K.J. Lauritsen, H.J. List, R. Reiter, A. Wellstein, A.T. Riegel, Oncogene 21(47), 7147–7155 (2002)
T. Blutstein, P.J. Baab, H.R. Zielke, J.A. Mong, Endocrinology 150(7), 3237–3244 (2009)
B. Mulac-Jericevic, R.A. Mullinax, F.J. DeMayo, J.P. Lydon, O.M. Conneely, Science 289(5485), 1751–1754 (2000)
J.K. Richer, B.M. Jacobsen, N.G. Manning, M.G. Abel, D.M. Wolf, K.B. Horwitz, J. Biol. Chem. 277(7), 5209–5218 (2002)
L. Tung, H. Abdel-Hafiz, T. Shen, D.M. Harvell, L.K. Nitao, J.K. Richer, C.A. Sartorius, G.S. Takimoto, K.B. Horwitz, Mol. Endocrinol. 20(11), 2656–2670 (2006)
E.J. Faivre, A.R. Daniel, C.J. Hillard, C.A. Lange, Mol. Endocrinol. 22(4), 823–837 (2008)
D.M. Lonard, S.Y. Tsai, B.W. O’Malley, Mol. Cell Biol. 24(1), 14–24 (2004)
R.C. Wu, J. Qin, P. Yi, J. Wong, S.Y. Tsai, M.J. Tsai, B.W. O’Malley, Mol. Cell 15(6), 937–949 (2004)
Acknowledgments
This study was supported by Consejo Nacional de Ciencia y Tecnología (project No. 100645), México.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hernández-Hernández, O.T., Rodríguez-Dorantes, M., González-Arenas, A. et al. Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines. Endocr 37, 194–200 (2010). https://doi.org/10.1007/s12020-009-9288-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9288-6